Showing results (1-10 of 54) with videos related to
Sort By:
Pageof 6
The Journal of Law & Economics|September 16, 2014
Does Intellectual Property Restrict Output? An Analysis of Pharmaceutical MarketsDarius Lakdawalla, Tomas PhilipsonEconomics and Human Biology|September 15, 2009
The growth of obesity and technological changeDarius Lakdawalla, Tomas PhilipsonForum for Health Economics & Policy|August 18, 2019
A Cost-Benefit Analysis of Using Evidence of Effectiveness in Terms of Progression Free Survival in Making Reimbursement Decisions on New Cancer TherapiesWarren Stevens, Tomas Philipson, Yanyu Wu, et al.Journal of Public Economics|May 11, 2010
Innovation and The Welfare Effects of Public Drug InsuranceDarius Lakdawalla, Neeraj SoodThe Review of Economics and Statistics|May 5, 2015
Insurers' Negotiating Leverage and the External Effects of Medicare Part DDarius Lakdawalla, Wesley YinJAMA Network Open|May 5, 2021
Association of Drug Rebates and Competition With Out-of-Pocket Coinsurance in Medicare Part D, 2014 to 2018Darius Lakdawalla, Meng LiJournal of Public Economics|September 3, 2013
Health Insurance as a Two-Part Pricing ContractDarius Lakdawalla, Neeraj SoodValue in Health : the Journal of the International Society for Pharmacoeconomics and Outcomes Research|December 20, 2025
A Practical Method for Estimating GRACE Utilities and Willingness to Pay CorrectionsAnirban Basu, Darius LakdawallaAdvances in Health Economics and Health Services Research|June 26, 2010
Patents, innovation, and the welfare effects of Medicare Part DAdam Gailey, Darius Lakdawalla, Neeraj SoodMedical Care|December 29, 2007
Chronic disease and severe disability among working-age populationsJay Bhattacharya, Kavita Choudhry, Darius LakdawallaPageof 6